Hydrix Limited (HYD) AI Stock Analysis

• Market Cap: AU$4.36M
• Dividend Yield: N/A
• Average Volume (3M): 124.48K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.06
• Revenue Growth: -13.05%
• EPS Growth: -184.09%
• Country: AU
• Employees: 55
• Sector: Technology
• Sector Strength: 98
• Industry: Hardware, Equipment & Parts
• EPS (TTM): >-0.01
• Shares Outstanding: 272,768,860
• 10 Day Avg. Volume: 132,037
• 30 Day Avg. Volume: 124,479
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 0

• Rating: 50 Neutral
• Price Target: AU$0.00 ▼(-100.00% Downside)

Hydrix Limited's overall stock score is primarily influenced by its weak financial performance, characterized by declining revenue and high leverage. Technical analysis offers some optimism with bullish trends, but valuation concerns persist due to negative earnings. The absence of earnings call data and corporate events means these factors do not influence the score.

Hydrix Limited Business Overview & Revenue Model

Company Description

Hydrix Limited provides product design, engineering, and regulatory services in Australia, Singapore, Europe, North America, and internationally. It operates through two segments: Hydrix Services and Hydrix Medical. It provides cardiovascular products, such as The GUARDIAN, a cardiac monitoring and alerting device that reduces the stresses of living; Phyzhon PHYRARI FFR-Wire enables cardiologists to combine diagnosis procedures with delivery of therapy including stents; and LUDO, a customizable plug-and-play platform that provides critical tools to start MCS pump development. The company also offers a range of services, including product development, regulatory and clinical consulting, and technology commercialization. It serves medical, consumer, industrial, utilities, defense, aerospace, and mining industries. The company was formerly known as Panorama Synergy Limited and changed its name to Hydrix Limited in November 2018. Hydrix Limited was incorporated in 1993 and is headquartered in Mulgrave, Australia

How the Company Makes Money

Hydrix Limited generates revenue through its diversified service offerings, primarily in the design and engineering of high-tech products. The company's key revenue streams include fees from product development services, consulting, and licensing agreements. Hydrix collaborates with companies in the medical technology sector to develop innovative medical devices, contributing significantly to its earnings. Additionally, partnerships with companies in consumer electronics and industrial systems sectors enable Hydrix to leverage its engineering expertise, generating additional income through long-term contracts and service agreements.

Hydrix Limited Financial Statement Overview

Summary

Hydrix Limited faces substantial financial challenges with declining revenues, negative profit margins, high leverage, and cash flow deficiencies. Negative equity and a high debt-to-equity ratio present significant financial risks.

Income Statement

Hydrix Limited's income statement indicates financial challenges, with declining revenue and negative profit margins. The company reported a significant net loss, and both EBIT and EBITDA margins are negative, reflecting operational inefficiencies. The revenue growth rate is negative, showing a downward trend in sales.

Balance Sheet

The balance sheet reveals a precarious financial position, with negative stockholders' equity indicating potential solvency issues. The high debt-to-equity ratio highlights significant leverage, increasing financial risk. The equity ratio is also negative, suggesting that liabilities exceed assets.

Cash Flow

Cash flow analysis shows persistent negative free cash flow, indicating the company is not generating sufficient cash to cover its capital expenditures. The operating cash flow to net income ratio is unfavorable, reflecting cash flow challenges. However, some relief is provided by positive financing cash flow.

Breakdown	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	10.61M	13.16M	10.33M	7.45M	14.93M
Gross Profit	9.79M	-638.73K	-3.31M	-6.46M	569.70K
EBITDA	-7.92M	1.30M	-4.05M	-6.34M	-1.23M
Net Income	-9.56M	-396.93K	-5.55M	-9.78M	-3.22M
Balance Sheet
Total Assets	8.62M	14.58M	15.94M	19.38M	20.50M
Cash, Cash Equivalents and Short-Term Investments	914.27K	1.15M	1.94M	6.65M	1.69M
Total Debt	7.61M	4.73M	5.40M	5.97M	9.92M
Total Liabilities	11.98M	8.22M	12.66M	13.67M	18.20M
Stockholders Equity	-3.36M	6.35M	3.28M	5.71M	2.30M
Cash Flow
Free Cash Flow	-1.91M	-3.32M	-6.75M	-3.35M	-1.37M
Operating Cash Flow	-1.89M	-3.12M	-6.58M	-2.86M	-1.32M
Investing Cash Flow	-53.43K	-209.71K	-306.65K	-641.56K	-1.07M
Financing Cash Flow	1.71M	2.54M	2.18M	8.46M	3.84M

Hydrix Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.02
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:HYD, the sentiment is Positive. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.02, and above the 200-day MA of 0.02, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 73.26 is Negative, neither overbought nor oversold. The STOCH value of 150.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:HYD.

Hydrix Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
KNO	63 Neutral	AU$6.92M	47.78	-2.18%	―	-2.13%	81.58%
Sector *	61 Neutral	$34.87B	5.87	-10.42%	2.07%	6.72%	-8.84%
BCC	53 Neutral	AU$10.37M	―	-127.39%	―	-17.08%	-2263.16%
DVL	52 Neutral	AU$33.71M	―	-74.01%	―	-8.28%	35.71%
HYD	50 Neutral	AU$4.36M	―	-637.73%	―	-13.05%	-184.09%
X2M	46 Neutral	AU$9.75M	―	-1370.92%	―	-36.98%	41.43%
SIS	39 Underperform	AU$6.43M	―		―	-8.86%	38.46%

Hydrix Limited Corporate Events

Hydrix Limited Reports Strong June Quarter with Increased Sales and Contract Wins

Hydrix Limited announced a positive trading update for the June quarter, highlighting increased sales activity and recent contract wins that support near-term growth. The company reported $2.4 million in quarterly revenues, with significant contributions from cardiac and medtech products and emerging growth from defense clients. Hydrix secured 18 new and existing client contracts totaling $3.5 million in revenues and has 20 active clients with a potential future project revenue base of $40 million. Despite a $0.76 million operating loss, this marks a 45% improvement from the previous corresponding period, indicating a positive trend and potential for further revenue momentum in the coming months.

Hydrix Limited Announces Cessation of Securities

Hydrix Limited announced the cessation of 472,402 securities due to the expiry of options without exercise or conversion as of June 30, 2025. This development may impact the company’s capital structure and could influence stakeholder perceptions regarding the company’s financial strategies and market positioning.

Hydrix Limited Announces Cessation of Securities

Hydrix Limited announced the cessation of 264,751 securities due to the expiry of options or other convertible securities without exercise or conversion as of June 30, 2025. This update on the company’s issued capital may impact stakeholders by potentially altering the company’s financial structure and market positioning, reflecting a strategic decision in managing its securities.

Hydrix Limited Announces Cessation of Securities

Hydrix Limited announced the cessation of 3,750 securities, specifically options expiring on June 30, 2029, due to unmet conditions. This development may impact the company’s financial strategies and stakeholder interests, as it reflects on the company’s ability to meet certain operational conditions.

Hydrix Limited Announces Cessation of Securities

Hydrix Limited announced the cessation of 10,800 securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This cessation, effective June 30, 2025, may impact the company’s capital structure and could have implications for stakeholders regarding the company’s financial strategies and market positioning.

Hydrix Limited Announces Cessation of Securities

Hydrix Limited announced the cessation of 9,450 securities due to the lapse of conditional rights, as the conditions were not met by the deadline of June 30, 2025. This cessation could impact the company’s capital structure and may influence stakeholder perceptions of its financial health and strategic direction.